Steinberg, and apparently not quoting Kirsner, diagnoses 4 psychoanalytic training institutes in New York, Boston, Chicago, and Los Angeles, as being "pathologically functioning," "dominated by narcissistic characters," and exhibiting "childlessness and fratricidal behaviour." He further states that they have "irredeemable narcissism, even paranoia." Such psychopolitical descriptors are usually reserved for books concerning fascists, dictators, or the present "war on evil," and appear politically dismissive rather than offering useful dynamic insights or objective criticism. He wonders about comparing the functioning of psychoanalytic institutes with other institutions, such as universities and hospitals and their leaders. My recent books (3, 4) have attempted to look at some of these factors that faced the founders and affected the functioning of the Clarke Institute of Psychiatry and the Toronto Psychoanalytic Institute. Many of these shortcomings cross the boundaries of most, if not all, professional groups. Possibly, some of the factors mentioned are intrinsic, especially in groups wherein charismatic founders devote themselves and attempt to control others to establish certain goals.
There is much to be critical about with respect to these "elite groups," especially the politics that invariably go with founding and maintaining values, theoretical positions, and even ideologies in all these organizations. They do have much to be humble about, especially at times when interpersonal differences have been exploited and peoples' feelings have been overlooked yet their leadership, their energetic involvement, and their command are often necessary to establish such organizations, even when there is also bias and obvious self-interest. Eventually, founders and initial leaders become a hindrance, are counterproductive to the now-established groups' aims, and are, in fact, functionally replaced, even though they are still listed as a professor or as a training analyst.
Gedo's book, Spleen and Nostalgia, is quoted and conveys the bitterness of one of America's most important and decorated analysts, who also feels overlooked and irrelevant at the end of his productive career. It is not only the people in psychoanalytic organizations who feel they didn't get the chance to influence change and scientific thought who have resentments: some of the very leaders who apparently had been ambitious and successful feel they have not accomplished what they had hoped and have not been acknowledged for what they have accomplished. I will not criticize Dr Steinerberg for merely being the messenger of Kirsner's concerns and criticisms regarding the psychoanalytic institutes' apparent practice of "anointment, . . . claimed knowledge and implied qualifications" in place of substantive educational accomplishments or an egalitarian interest for the society.
It is unfortunate to focus primarily on the failures of organizations and to describe their functioning primarily in terms of personality pathology. This does a disservice to many and does not enlighten those who wish to avoid the mistakes of the past or to convey to the reader the complexities of emerging professional group dynamics. 
Reply: Unfree Associations: Inside Psychoanalytic Institutes
Dear Editor:
Dr Frayn is critical of me for being the messenger of Kirsner's concerns and criticisms about psychoanalytic institutes; he apparently takes exception to my reading of Kirsner's description. I do not believe that my review was one-sided, as Dr Frayn indicated. In suggesting that the author might have compared psychoanalytic institutes with other institutions, I was implying that the former might not suffer by the comparison. I also pointed out that Kirsner was aware of positive qualities in the central figures but focused on activities illustrating less admirable characteristics. I indicated that this text is extremely well documented and that Kirsner's reporting appears balanced, fair, and objective. As well, in the concluding chapter, Kirsner offers constructive opinions about how psychoanalytic institutions need to change. Dr Frayn may well be correct in suggesting that many of the shortcomings Kirsner describes cross the boundaries of most, if not all, professional groups. This does not invalidate analysis of the groups Kirsner describes. In fairness to Dr Frayn, Kirsner certainly devotes much (in my opinion, too much) space to describing the failures of the organizations in question. I cannot agree that this necessarily does a disservice to many and fails to enlighten those who wish to avoid the mistakes of the past. It may be painful to read about such serious difficulties in respected professional organizations. However, in my opinion, uncovering these difficulties is analogous to uncovering one's personal difficulties in psychoanalysis and is necessary for improvements to be made.
Paul Steinberg, MD, FRCPC Edmonton, Alberta

Improving the Mood Disorder Questionnaire to Detect Bipolar II Disorder
The Mood Disorder Questionnaire (MDQ) (1) is a self-assessment screening tool for a broad diagnosis of the bipolar spectrum (that is, bipolar I [BD I], bipolar II [BD II], and bipolar not otherwise specified [BD NOS], according to DSM-IV criteria). It has 13 questions covering hypomania symptoms, clustering of symptoms, and impaired functioning. Its criteria for a diagnosis within the bipolar spectrum are more than 6 positive questions, plus clustering of symptoms, plus moderate-to-severe impairment. Compared with the Structured Clinical Interview for DSM-III-R (SCID), the MDQ had sensitivity of 73% and specificity of 90% for a bipolar spectrum diagnosis in clinical samples (1) and sensitivity of 28% and specificity of 97% in community samples (2) . According to the MDQ, community frequency of the bipolar spectrum was 3.4%-a figure similar to that achieved by adding figures reported in the DSM-IV (meaning underdiagnosis of BD II [3, 4] ). One limitation of the MDQ is the required moderate-to-severe impairment (5) . Because hypomania in BD II often shows improved functioning (6,7), the MDQ is biased against BD II and should be improved to better detect it. Using a semistructured interview focusing on past overactivity, clinicians probing for past hypomania found (with high interrater agreement) that BD II was present in approximately 50% of clinical and community samples of subjects with depression (8-11).
This study aimed to test the usefulness of the MDQ in a clinical sample and to modify it to increase its detection of BD II. In a private practice, 101 consecutively remitted outpatients with BD I, BD II, or major depressive disorder (MDD) were given the MDQ during follow-up visits. Soon after, they were interviewed with the SCID-Clinician Version (SCID-CV) (12). The interviewer was blind to MDQ results. Setting and interview methods are reported in detail elsewhere (9,13). There were many more remitted BD (BD I and BD II) than MDD patients because BD patients were followed up more frequently.
Results
According to the MDQ, frequency of BD was 17.8% (n = 18). According to the SCID-CV, frequency of BD I was 16.8% (n = 17), frequency of BD II was 59.4% (n = 60), and frequency of MDD was 23.7% (n = 24). To test whether this big difference in BD frequency observed between the MDQ and the SCID-CV was related to the the MDQ's impairment criterion, calculations were remade after deleting it. The modified MDQ was called the MDQ7, indicating a cluster of at least 7 positive items. The MDQ7 found 65 cases of BD; of these, the SCID-CV identified 57 (87.8%) as BD (BD 1, 24.2%; BD II, 63.6%) Among the cases not identified by the MDQ7 (n = 33), 18 (54.2%) were classified by the SCID-CV as BD (BD I, 2.8%; BD II, 51.4%).
Using Stata statistical software (14), we studied agreement between the MDQ, the MDQ7, and the SCID-CV. Comparing the MDQ and the SCID-CV for BD I, we found agreement = 79.2%, kappa = 0.27, and P = 0.0029. Comparing the MDQ and the SCID-CV for BD II, we found agreement = 36.6%, kappa = -0.13, and P = 0.9747. Next, we compared the MDQ7 and the SCID-CV for BD I, finding agreement = 49.5%, kappa = 0.16, and P = 0.0031. When we compared the MDQ7 and the SCID-CV for BD II, we found agreement = 58.4%, kappa = 0.11, and P = 0.1172. Then, we compared the MDQ and the SCID-CV for BD (BD I + BD II) and found agreement = 33.6%, kappa = 0.00, and P = 0.4328. Comparing the MDQ7 and the SCID-CV for BD (BD I + BD II), we found agreement = 73.2%, kappa = 0.36, and P = 0.0001. Logistic regression was used to study associations, sensitivity, and specificity. The MDQ was not significantly associated with SCID-CV BD (Odds Ratio = 1.1, z = 0.17, P = 0.866). The MDQ7 was associated with SCID-CV BD (Odds Ratio = 6.1, z = 3.5, P = 0.000), giving a sensitivity of 87.8% and a specificity of 45.7% for predicting SCID-CV BD.
The MDQ had much higher agreement with the SCID-CV for the detection of BD I, compared with BD II, and low agreement for the detection of BD (BD I + BD II). By contrast, the MDQ7 had high agreement with SCID-CV for the detection of BD. Because the MDQ is a screening tool for bipolar spectrum detection (which then needs to be followed by clinical evaluation), sensitivity is more important than specificity. The modified MDQ's high sensitivity for BD detection (specifically, modified by deleting the impairment criterion) means few false negatives, or few subjects lost for clinical evaluation (which would then lead to the final diagnosis). The high underdetection of BD II by the MDQ can thus be improved by deleting its impairment criterion.
